- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2016–2023 · research · R35
New Paradigms for Targeting Truncal Driver Mutations
William G. Kaelin · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2021 · program · P01
Comprehensive dissection of the CLL genome and phenome to improve patient outcomes
Catherine Ju-Ying Wu · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2021 · research · R50
Stapled Peptides for Protein Interaction Research and Therapeutic Targeting in Human Cancer
Gregory Howard Bird · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2019 · grant · PCRP
Genome-Scale Synthetic Lethal Screens in Prostate Cancer Cells by CHRISPR -Cas9 System
Neel Shah · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2016–2020 · research · R01
Organizational Approaches to Total Worker Health for Low-Income Workers
Glorian C Sorensen · Dana-Farber Cancer Institute · funded by National Institute for Occupational Safety and Health
2016–2018 · career development · K99
Role of SNF5 in regulating SWI/SNF complex assembly & targeting in rhabdoid tumor
Xiaofeng Wang · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2019 · research · R01
Computational Methods for Genome-Wide CRISPR Screens
Xiaole Shirley Liu · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2018 · research · R21
Biophysical and Mechanistic Determinants for Cancer Cell Import of Hydrocarbon-Stapled Peptides
Loren David Walensky · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2020 · grant · PCRP
Development of Precision Neoadjuvant-Adjuvant Therapies
Mary-Ellen Taplin · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2016–2021 · research · R01
Novel functions of D-type and E-type cyclins in normal and in cancer cells
Peter Sicinski · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2020 · research · R01
Organizational Approaches to Total Worker Health for Low-Income Workers
Glorian C Sorensen · Dana-Farber Cancer Institute · funded by National Institute for Occupational Safety and Health
2016–2026 · program · P01
Comprehensive dissection of the CLL genome & phenome to improve patient outcomes
Catherine Ju-Ying Wu · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2020 · research · R00
Lineage-based inference of cell state transition dynamics in development and disease
Sahand Hormoz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2019 · career development · K99
Investigation and targeting of the transcriptional and epigenetic landscape of Small Cell Lung Cancer
Camilla L Christensen · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2022 · research · R01
Novel functions of D-type and E-type cyclins in normal and in cancer cells
Peter Sicinski · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2021 · career development · K07
Material Hardship as a Targetable Measure of Poverty in Pediatric Cancer
Kira O. Bona · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016 · research · Research
Comparing Two Approaches for Providing Follow-Up Care to Patients after Hematopoietic Cell Transplantation
Gregory A. Abel · Dana-Farber Cancer Institute · funded by Patient-Centered Outcomes Research Institute
2016–2021 · training · T32
Cancer Immunology Training Grant
Kai W Wucherpfennig · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2021 · cooperative agreement · U01
Circulating Biomarker Consortium for Pancreatic Cancer Early Detection
Brian Matthew Wolpin · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2020 · research · R00
Lineage-based inference of cell state transition dynamics in development and disease
Sahand Hormoz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2018 · career development · K99
Investigation and targeting of the transcriptional and epigenetic landscape of Small Cell Lung Cancer
Camilla L Christensen · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2020 · research · R01
(PQ5) Investigation of intertumoral and intratumoral heterogeneity of mitochondrial apoptotic sensitivity
Anthony G Letai · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2018 · research · R21
Barriers to Hospice and Palliative Care Utilization Among Adolescent and Young Adult Cancer Patients Living in Poverty
Jennifer W Mack · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2021 · program · P01
Targeting Immunogenicity to the MPER Hinge and C-helix for BNAb Elicitation
Ellis L Reinherz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2019 · grant · PCRP
A Mechanistic Study to Explain the Survival Benefit of Chemo-Hormonal Therapy in Metastatic Castration-Sensitive Prostate Cancer
Christopher Sweeney · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2016–2021 · research · R01
(PQ5) Investigation of intertumoral and intratumoral heterogeneity of mitochondrial apoptotic sensitivity
Anthony G Letai · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2030 · research · R35
Integrating targeted therapy and immunotherapy to break through cancer
Jean Zhao · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2018 · grant · PRCRP
Developing Mouse Models of Stomach Cancer with CRISPR/Cas9 Technologies and Environmental Exposures
Adam Bass · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2016–2021 · research · R01
Neuroimmune mechanisms of depression in adults with HIV infection
Dana H. Gabuzda · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2021 · research · R01
Conformational Landscape of the HIV-1 Envelope Glycoproteins
Joseph G Sodroski · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2021 · career development · K07
Video Informed Consent Tools to Improve Care for Patients With Advanced Pancreatic Cancer
Andrea C Enzinger · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2021 · research · R01
Therapeutically Targeting Plasmacytoid Dendritic Cells in Multiple Myeloma
Kenneth C. Anderson · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2019 · research · R01
USP7 inhibitors for the treatment of multiple myeloma
Sara J Buhrlage · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2026 · program · P01
Comprehensive dissection of the CLL genome & phenome to improve patient outcomes
Catherine Ju-Ying Wu · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2023 · research · R35
Developing novel targeted therapeutics integrated with immunotherapy-based approaches to make breakthroughs in metastatic breast cancer
Jean Zhao · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2022 · research · R01
(PQ9) The role of Bclw (bcl2l2) in preventing chemotherapy induced neuropathy
Rosalind A. Segal · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2022 · career development · K08
Determining the Role of BCOR Mutations in Myeloid Malignancies
Robert Coleman Lindsley · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2017 · career development · K08
Elucidating KRAS-specific vulnerabilities in pancreatic cancer
Mandar Deepak Muzumdar · Dana-Farber Cancer Institute · funded by National Institutes of Health
2016–2019 · grant · PRCRP
Therapeutic Strategies for MYCN-Amplified Neuroblastoma
Rani George · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2016–2023 · research · R35
Mechanisms and Vulnerabilities of Aberrant Transcriptional Enhancers in Cancer
A. Thomas Look · Dana-Farber Cancer Institute · funded by National Institutes of Health
